BRI News

Learn about BRI's world-renowned advancements in autoimmune disease research.

Back to all news

News focused on: Type 1 Diabetes (T1D); Type 1 Diabetes TrialNet

Blog BRI Building Rear

Seattle, WA - Aug 29, 2023

Benaroya Research Institute Awarded $3.1 Million National Institutes of Health Grant to Study the Inflammatory Cycle of Common Skin Diseases

Monitoring T cells may allow prevention of type 1 diabetes

October 13, 2022

New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment

Seattle, WA - Oct 5, 2022

New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment

Exploring autoimmunity's regulatory roots

January 14, 2022

Autoimmunity in Down Syndrome Arises From Rapid Immune Aging

Gene-edited T cells to treat diabetes inch closer to clinical trials

News Science in Seattle

Hybrid Insulin Peptides are Recognized by Human T Cells in the Context of DRB1*04:01

Healing the Immune System: Autoimmune Breakthroughs Offer New Hope

Biological 'atlas' shows dual personality for immune cells that cause type 1 diabetes

February 6, 2020

Screening Kids for Type 1 Diabetes in Primary Care Is Feasible

Blog T1D Diabetes Medical Technology

January 9, 2020

Bills in Washington State Would Lower Price of Insulin, Other Prescriptions

Seattle, WA - Dec 17, 2019

Type 1 Diabetes Discovery Opens Door to Game-Changing Treatment Strategies

Blog T1D Diabetes Medical Technology

October 7, 2019

Groundbreaking Immunotherapy Can Delay Onset of Diabetes for 2 Years

Watch video ➡

Blog T1D Diabetes Medical Technology

October 7, 2019

Groundbreaking Immunotherapy Can Delay Onset of Diabetes for 2 Years

1 2 3 4 5

Back to all news